Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
M. Gelo-Pujic et al. / Tetrahedron: Asymmetry 17 (2006) 2000–2005
2001
On the other hand, asymmetric hydrogen transfer from a
hydrogen donor is an oxido-redox process catalyzed by
an organometallic complex. One of the most efficient asym-
metric catalysts developed by Noyori22 contains a mono-
tosylated chiral diamine as the ligand associated to a
ruthenium complex. This system was shown to be very effi-
cient, enantioselective and independent of the substrate.
The mechanism of hydrogen transfer has been described
by Noyori.23 The monotosylated chiral diamine and the
ruthenium complex form an active catalyst with 18 elec-
trons, which loses two electrons in the presence of a base.
The 16 electron complex is then hydrogenated by the do-
nor, generally 2-propanol. This active catalyst is finally
able to reduce the aromatic ketone via a six-centre mecha-
nism.24 Both, 18- and 16-electron complexes have been iso-
lated and their structures have been determined by X-
ray.23a The results confirmed the hypothesis of the reduc-
tion by hydrogen transferred from ruthenium and not the
metal alcoholate as in the case of Meerwein–Ponndorf–
Verley reduction. The amino group is necessary for efficient
catalysis by complexing the carbonyl group of the sub-
strate. The catalytic system described has been efficiently
employed in reduction of various aromatic ketones.22
ADH) in the reduction of 1 was performed under different
pH conditions, cofactor concentration, cofactor regenera-
tion system and the addition of an organic cosolvent.
The substrate concentration was kept constant at 5 mg/
ml (20 mM). Under all conditions assayed only HLADH
and L. kefir ADH showed activity and transformed 1 in
a very moderate yield, but with 100% ee into the alcohol
2 (Fig. 2). Both enzymes reduced 1 but with the opposite
enantioselectivity. While HLADH gave the (S)-enantio-
mer, L. kefir ADH gave an anti-Prelog’s configuration,
that is, the R-alcohol. Product configurations and the
enantioselectivity of the enzymatic reductions were deter-
mined by a chiral GC comparison of the reduction prod-
ucts with the authentic samples.
OH
CF3
O
H
CF3
D
A
L
L
2
(S)-
CF3
H
.
k
e
f
i
r
CF3
NAD(P)+
OH
OH
NAD(P)H
1
CF3
We have applied two of the above described methodologies
in the reduction of 1-[3,5-bis(trifluoromethyl)phenyl]etha-
none 1. Commercially available oxido-reductases, as well
as microbial strains expressing these activities were screened.
On the other hand, numerous chiral ligands associated to the
ruthenium-p-cymene complex were screened under the con-
ditions of homogenous asymmetric catalysis. Our objective
was to evaluate the diversity of our strain collection and of
the (per)fluorosulfonyl-diamine ligands in the reduction
and secondly, to obtain the alcohol of (R)-configuration.
O
2
(R)-
CF3
Figure 2.
The results are summarized in Table 1. A little activity was
obtained without the recycling of the cofactor. When a sec-
ondary alcohol such as 2-propanol or cyclopentanol was
used, the reduction was more efficient. The secondary alco-
hol has a dual role: first it serves to recycle the cofactor and
secondly it enables better solubility of the substrate in the
aqueous medium. However, by increasing the concentra-
tion of 2-propanol added, the yield of reduction decreased
slightly. As the product of 2-propanol oxidation is acetone,
it could possibly act as a competitive substrate of the dehy-
drogenase. To check this possibility, the cofactor concen-
tration was increased for 35% (from 2 to 2.7 mM) and we
observed a 50% increase in the yield of reduction. Very
likely, both phenomena are taking place, that is, a substrate
competition and a cofactor depletion, but it was not inves-
tigated further.
1-[3,5-Bis(trifluoromethyl)phenyl]ethanone 1 is a key pre-
cursor of (R)-1-[3,5-bis-(trifluoromethyl)phenyl]ethanol
(R)-2, a sub-structure of the tachykinin NK1 receptor
antagonist L-754030, a potent anti-depressant as shown
in Figure 1. Its structure is closely related to the structure
of MK869, shown recently to be efficient in patients with
major depressive disorder.25
CF3
CF3
F3C
O
O
OH
O
N
F3C
Table 1. Reduction of 1 (20 mM) with HLADH and L. kefir ADH
H
N
ADH
NAD(P)H 2-Propanol Time GC
ee (%)
O
F
(mM)
(ll)
(h)
yield (%)
CF3
CF3
HN N
Figure 1.
L-754030
1
2
(R)-
L. kefir
0.2
2
2
2.7
1
1
2.5
100
25
100
100
100
48
48
44
66
72
72
15
20
24
49
0
>99 (R)
>99 (S)
>99 (S)
>99 (S)
—
HLADH
HLADH
HLADH
HLADHa
HLADHb
2. Results and discussion
2.1. Bio-reductions
0
—
Conditions: 0.1 M phosphate buffer pH 7.8, 4.4–5 U/ml of ADH at 30 ꢁC
and 1300 rpm.
a Reaction in n-hexane.
b Reaction in acetonitrile.
A screening of commercially available alcohol dehydrogen-
ases (HLADH, YADH, BYADH and Lactobacillus kefir